RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Stockholders' equity

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Jun 30, 20255,968+22.69%
Jun 30, 20244,864+17.78%
Jun 30, 20234,130+22.89%
Jun 30, 20223,361+16.46%
Jun 30, 20212,886+15.56%
Jun 30, 20202,497+20.50%
Jun 30, 20192,072+0.64%
Jun 30, 20182,059+5.04%
Jun 30, 20171,960+15.66%
Jun 30, 20161,695+6.77%
Jun 30, 20151,587-9.72%
Jun 30, 20141,758+9.17%
Jun 30, 20131,611+0.18%
Jun 30, 20121,608-7.11%
Jun 30, 20111,731

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)